200 related articles for article (PubMed ID: 4710038)
41. Proceedings: use of the leucocyte-migration test to demonstrate specific cellular immunity in lymph-nodes draining colorectal cancer.
Guillou PJ; Giles GR
Br J Surg; 1973 Nov; 60(11):904-5. PubMed ID: 4752759
[No Abstract] [Full Text] [Related]
42. Monoclonal antibodies to human tumor antigens.
Steplewski Z
Transplant Proc; 1980 Sep; 12(3):384-7. PubMed ID: 7222217
[No Abstract] [Full Text] [Related]
43. Aspects of immunology in radiotherapy.
James KW
Mod Trends Radiother; 1972; 2():77-97. PubMed ID: 4563804
[No Abstract] [Full Text] [Related]
44. Significance of tumour associated antigens on human colonic carcinomata.
Embleton MJ
Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
46. [Specificity of lymphocytic reaction to tumor antigens--approaches to a cancer diagnosis in vitro?].
Muhrer KH
Fortschr Med; 1984 Jan; 102(3):45-8. PubMed ID: 6199270
[TBL] [Abstract][Full Text] [Related]
47. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
[TBL] [Abstract][Full Text] [Related]
48. Human tumor-associated antigens defined by monoclonal antibodies.
Reisfeld RA; Harper JR; Bumol TF
Crit Rev Immunol; 1984; 5(1):27-53. PubMed ID: 6400468
[TBL] [Abstract][Full Text] [Related]
49. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
50. Evaluation of a cell-mediated cytotoxicity assay utilizing 125 iododeoxyuridine-labeled tissue-culture target cells.
Oldham RK; Siwarski D; McCoy JL; Plata EJ; Herberman RB
Natl Cancer Inst Monogr; 1973 Jun; 37():49-58. PubMed ID: 4268324
[No Abstract] [Full Text] [Related]
51. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
Cohen AM; Ketcham AS; Morton DL
Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
[No Abstract] [Full Text] [Related]
52. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
53. Cancer disease predictive diagnosis: BAT/CD3-positive lymphocytes in cancer patients.
Hardy B; Raiter A; Rubin M; Sprecher E; Sella A; Flex D; Lelcuk S; Bsharah B; Mishaeli M; Niv Y
Int J Oncol; 2005 Apr; 26(4):971-5. PubMed ID: 15753991
[TBL] [Abstract][Full Text] [Related]
54. Cell-mediated cytotoxicity against human bladder cancer.
Bloom ET; Ossorio RC; Brosman SA
Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
[No Abstract] [Full Text] [Related]
55. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
Fink LM; Clarke SM
Prog Clin Pathol; 1984; 9():121-33. PubMed ID: 6364219
[No Abstract] [Full Text] [Related]
57. Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence.
Ikuta K; Nishi Y; Shimizu Y; Higashi H; Kitamoto N; Kato S; Fujita M; Nakano Y; Taguchi T; Naiki M
Biken J; 1982 Mar; 25(1):47-50. PubMed ID: 6982042
[TBL] [Abstract][Full Text] [Related]
58. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames.
Wang RF; Johnston SL; Zeng G; Topalian SL; Schwartzentruber DJ; Rosenberg SA
J Immunol; 1998 Oct; 161(7):3598-606. PubMed ID: 9759882
[TBL] [Abstract][Full Text] [Related]
59. [Study of cellular immunity indices in patients with malignant tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA
Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
[No Abstract] [Full Text] [Related]
60. Tumor immunity in melanoma patients as assessed by colony inhibition and microcytotoxicity methods: a preliminary report.
Byrne M; Heppner G; Stolbach L; Cummings F; McDonough E; Calabresi P
Natl Cancer Inst Monogr; 1973 Jun; 37():3-8. PubMed ID: 4713784
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
